{
    "cancelStatus": "1",
    "cancelDate": "2013-10-25",
    "cancelReason": [
        "841"
    ],
    "licid": "02022207",
    "validDate": "2018-06-11 00:00:00.000",
    "issueDate": "1998-06-11 00:00:00.000",
    "licKind": "02",
    "oldLicid": null,
    "certNo": "DHA00202220701",
    "prodNameC": "康利斯微脂粒注射劑",
    "prodNameE": "CAELYX CONCENTRATE FOR INFUSION",
    "indicationsName": [
        "CAELYX用於治療CD4數量低下(<200 CD4 LYMPHOCYTES\/MM3）和黏膜、皮膚或內臟有病變的AIDS RELATED KAPOSI'S SARCOMA的病人。CAELYX用於治療曾接受第一線含PLATINUM及PACLITAXEL化學治療而失敗者或再復發之進行性或轉移性卵巢癌病人。CAELYX可用於單一治療有心臟疾病風險考量之轉移性乳癌患者。Caelyx與bortezomib併用治療於曾接受過至少一種治療方式且已經接受或不適宜接受骨髓移植的進展性多發性骨髓瘤病人。"
    ],
    "does": "2270",
    "packageUnit": [
        {
            "packageSpec": "100小瓶以下",
            "packageUnit": "03"
        },
        {
            "packageSpec": "10公撮",
            "packageUnit": "13"
        }
    ],
    "medMCode": "05",
    "maMedCode": null,
    "medDCode": null,
    "ingredientsDesc": [
        "DOXORUBICIN HCL"
    ],
    "restraintItemsCode": [
        "02",
        "07",
        "53"
    ],
    "applicantName": "嬌生股份有限公司",
    "applicantAddr": "台北市大安區敦化南路二段319號4、5樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": null,
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "BEN VENUE LAB. INC.",
            "factoryAddr": "300 NORTHFIELD ROAD, BEDFORD, OHIO 44146, U.S.A.",
            "factoryCompanyAddr": "300 NORTHFIELD ROAD, BEDFORD, OHIO 44146-0568, U.S.A.",
            "countryCode": "US",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FUS0030000",
            "factoryInfo": null,
            "qsd": null
        },
        {
            "factoryCode": "2",
            "factoryName": "JANSSEN PHARMACEUTICA N.V.",
            "factoryAddr": "TURNHOUTSEWEG 30, B-2340, BEERSE, BELGIUM",
            "factoryCompanyAddr": null,
            "countryCode": "BE",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FBE0009000",
            "factoryInfo": null,
            "qsd": null
        },
        {
            "factoryCode": "2",
            "factoryName": "DSM Pharmaceuticals,Inc.",
            "factoryAddr": "5900 Martin Luther King Jr. Highway,Greenville,NC27834,USA",
            "factoryCompanyAddr": "",
            "countryCode": "US",
            "processCode": [
                {
                    "value": "8F",
                    "name": "Sterile filtration process and primary packaging"
                }
            ],
            "processCodeStr": "8F;Sterile filtration process and primary packaging",
            "factoryKind": "M",
            "factoryNo": "FUS0030300",
            "factoryInfo": null,
            "qsd": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1003000610",
            "ingredientsDesc": "DOXORUBICIN HCL",
            "concentDesc": "(PEGYLATED LIPOSOMAL",
            "concent": "2.0000",
            "concentUnit": "001",
            "seq": "10",
            "prescription_seq": "0",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01DB01"
        }
    ],
    "licBaseId": "675A920F-086D-4169-B52A-E95482365C63"
}